Kawaguchi S, Kikuchi K, Ishii S, Takada Y, Kobayashi S, Uede T
Department of Orthopedic Surgery, Sapporo Medical College.
Jpn J Cancer Res. 1992 Dec;83(12):1304-16. doi: 10.1111/j.1349-7006.1992.tb02763.x.
To elucidate the role of VLA-4 (alpha 4 beta 1 integrin) in tumor metastasis, we have transfected cDNA coding alpha 4 subunit into human fibrosarcoma (HT1080) cells. VLA-4-overexpressing HT-VC1 cells exhibited increased ability to interact with known ligands for VLA-4, such as CS1 peptide and VCAM-1 (vascular cell adhesion molecule-1). In addition, the in vitro invasive ability of HT-VC1 cells was augmented and the mRNA for type IV collagenase was increased in HT-VC1 cells. The induction of VCAM-1 molecules on lung endothelial cells of nude mice by tumor necrosis factor-alpha treatment resulted in augmentation of in vivo HT-VC1 cell adhesion to the lung endothelial cells. Thus, the VLA-4 molecules on tumor cells initiate an adhesive interaction with VCAM-1 molecules on endothelial cells, that is important for hematogenous metastasis.
为阐明VLA-4(α4β1整合素)在肿瘤转移中的作用,我们已将编码α4亚基的cDNA转染到人纤维肉瘤(HT1080)细胞中。过表达VLA-4的HT-VC1细胞与VLA-4已知配体(如CS1肽和VCAM-1(血管细胞粘附分子-1))相互作用的能力增强。此外,HT-VC1细胞的体外侵袭能力增强,且HT-VC1细胞中IV型胶原酶的mRNA增加。肿瘤坏死因子-α处理裸鼠肺内皮细胞可诱导VCAM-1分子,导致体内HT-VC1细胞与肺内皮细胞的粘附增强。因此,肿瘤细胞上的VLA-4分子与内皮细胞上的VCAM-1分子引发粘附相互作用,这对血行转移很重要。